Back to search

Ireland· IE-PA-PA2059/008/002

Geloplasma Solution for Infusion (Polyolefine/Freeflex Bag)

A blood substitutes and plasma protein fractions product containing modified liquid gelatine + sodium chloride + magnesium chloride hexahydrate + potassium chloride, registered in Ireland by Fresenius Kabi Deutschland GmbH. The same ATC class is registered in 7 of our 19 countries.

ATC B05AA

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedGeloplasma Solution for Infusion (Pol…ATCB05AAREGISTER NO.IE-PA-PA2059/008/002PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Modified liquid gelatine + sodium chloride + magnesium chloride hexahydrate + potassium chloride is registered in 7 of 19 countries.

Countries holding a registration under ATC B05AA (blood substitutes and plasma protein fractions), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 4 of them publish a price we can compare per daily dose

Modified liquid gelatine + sodium chloride + magnesium chloride hexahydrate + potassium chloride · ATC B05AA

7 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Modified liquid gelatine + Sodium chloride + Magnesium chloride hexahydrate + Potassium chloride
Manufacturer
Fresenius Kabi Deutschland GmbH
Country
Ireland (IE)
ATC code
B05AA
ATC class
Blood substitutes and plasma protein fractions
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2059/008/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0ddcaa9-3581-43c7-9890-796c42818c72
GET /v1/drugs/e0ddcaa9-3581-43c7-9890-796c42818c72?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B05AA"
  ],
  "strength": null,
  "pa_number": "PA2059/008/002",
  "substances": [
    "Modified liquid gelatine",
    "Sodium chloride",
    "Magnesium chloride hexahydrate",
    "Potassium chloride",
    "Sodium (s)-lactate solution"
  ],
  "legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "10/09/2010",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about modified liquid gelatine + sodium chloride + magnesium chloride hexahydrate + potassium chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.